Psychiatry and Neurology, Neurology · Canton, GA
NPI
1710149455
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
145 Riverstone Ter, Ste 102
Canton, GA, 30114
Phone (767) 886-6363
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
12,504 services
Medicare patients, 2024
546
Average age 74
Drug cost, 2024
$3.3M
5,909 prescriptions
Company payments, 2025
$4,423
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saima Khurram was code J0585 (injection, onabotulinumtoxina, 1 unit), 10,900 times for 24 patients. In total Saima Khurram billed 12,504 services in 42 codes, and Medicare paid $197K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 10,900 | 24 | $4.89 | $53K |
| 99214 Office E&M - Established | Office | 487 | 282 | $96.51 | $47K |
| 99213 Office E&M - Established | Office | 353 | 239 | $68.48 | $24K |
| 99205 Office E&M - New | Office | 96 | 96 | $167.51 | $16K |
| 99223 Hospital E&M - Initial | Facility | 93 | 93 | $134.38 | $12K |
| 99215 Office E&M - Established | Office | 63 | 53 | $140.95 | $8,880 |
| 95886 Electrical Nerve Conductivity | Office | 59 | 56 | $73.65 | $4,345 |
| 99204 Office E&M - New | Office | 45 | 45 | $119.03 | $5,356 |
| 99233 Hospital E&M - Subsequent | Facility | 41 | 36 | $92.02 | $3,773 |
| 99212 Office E&M - Established | Office | 37 | 31 | $39.98 | $1,479 |
| 95816 Neurologic | Facility | 34 | 33 | $42.21 | $1,435 |
| 95910 Electrical Nerve Conductivity | Office | 30 | 30 | $136.69 | $4,101 |
| 64615 Musculoskeletal | Office | 25 | 15 | $123.03 | $3,076 |
| 95908 Electrical Nerve Conductivity | Office | 15 | 14 | $76.25 | $1,144 |
By year: 2022 $200K for 11,974 services; 2023 $174K for 8,417 services; 2024 $197K for 12,504 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saima Khurram prescribed most often to Medicare patients was Memantine Hcl, with 493 prescriptions and refills. In total Saima Khurram wrote 5,909 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 493 | 941 | 155 | $13K |
| Gabapentin Generic | 443 | 799 | 131 | $9,033 |
| Pregabalin Generic | 350 | 558 | 103 | $9,561 |
| Donepezil Hcl Generic | 342 | 743 | 120 | $2,994 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 325 | 687 | 98 | $8,471 |
| Trazodone Hcl Generic | 225 | 372 | 60 | $912 |
| Duloxetine Hcl Generic | 225 | 353 | 60 | $5,379 |
| Levetiracetam Generic | 169 | 307 | 49 | $4,897 |
| Tizanidine Hcl Generic | 147 | 186 | 39 | $793 |
| Divalproex Sodium Generic | 144 | 229 | 36 | $2,132 |
| Clonazepam Generic | 122 | 147 | 24 | $602 |
| Quetiapine Fumarate Generic | 117 | 190 | 32 | $1,315 |
| Ropinirole Hcl Generic | 109 | 236 | 34 | $2,210 |
| Sertraline Hcl Generic | 105 | 196 | 28 | $662 |
| Botox Onabotulinumtoxina | 101 | 256 | 38 | $121K |
Brand drugs: - claims; generic drugs: 5,198 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saima Khurram $4,423 ($4,423 in general payments such as food, travel and fees) from 33 companies. The largest payer was UCB, Inc. with $397.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 15 | $397 |
| Abbvie Inc. ABBV | 17 | $393 |
| Janssen Biotech, Inc. JNJ | 9 | $374 |
| Biogen, Inc. BIIB | 10 | $342 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $318 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $269 |
| Pfizer Inc. PFE | 11 | $269 |
| Axsome Therapeutics, Inc. AXSM | 6 | $228 |
| CSL Behring CSL.AX | 11 | $199 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $186 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.